Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Clinical trial NCT01415752 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT01415752
- Sponsor
- Eastern Cooperative Oncology Group
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-08-09
- Primary completion
- 2023-02-25
- Enrollment
- 373
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.